BIO leadership shakeup followed clashes with board

from POLITICO's Pulse Check · host POLITICO

The leading industry group for biopharmaceutical companies is reeling after the departure of its CEO — just as the Biden administration is poised to begin implementing a new law aimed at reducing drug prices and as the balance of power could shift in Congress. Megan Wilson talks with Katherine Ellen Foley about the turmoil at the industry group. Plus, Chris Hammond, a Covid long-hauler, shares what life has been like for him, the Johns Hopkins trials he's a part of, and why he's not optimistic about additional Covid funding from Congress. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Oct 31, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

BIO leadership shakeup followed clashes with board

0:00 13:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of POLITICO's Pulse Check?

This episode is 13 minutes long.

When was this POLITICO's Pulse Check episode published?

This episode was published on October 31, 2022.

Can I download this POLITICO's Pulse Check episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!